1. Home/
  2. Compounds/
  3. doxorubicin:navitoclax (2:1 mol/mol)

doxorubicin:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2doxorubicin:navitoclax (2:1 mol/mol)
PharmacoGx doxorubicin:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to doxorubicin:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA KYAT3 CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA KIF26A CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA GPR173 CTRPv2 pan-cancer AAC 0.17 3e-05
mRNA COPS7A CTRPv2 pan-cancer AAC -0.15 3e-05
mRNA HIST1H2BD CTRPv2 pan-cancer AAC -0.14 3e-05
mRNA AC104581.1 CTRPv2 pan-cancer AAC 0.13 3e-05
mRNA RP3-403A15.5 CTRPv2 pan-cancer AAC 0.16 3e-05
mRNA MDH1B CTRPv2 pan-cancer AAC 0.14 3e-05
mRNA CSRNP3 CTRPv2 pan-cancer AAC 0.13 3e-05
mRNA ZNF672 CTRPv2 pan-cancer AAC 0.14 3e-05
Download CSV